Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1980 Sep;41(1):107–114.

Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors.

B E Ogden, H R Hill
PMCID: PMC1458224  PMID: 6253388

Abstract

In previous studies we have reported that patients with mild atopic eczema have enhanced lymphocyte mitogenesis while those with severe disease have markedly suppressed responses. Similarly, histamine in low concentrations enhanced mitogenesis while higher levels inhibit mitogen stimulated thymidine uptake. In the present study, we investigated the kinetics of this response and the interaction of histamine with its cell-surface receptors on lymphocytes. Histamine (10(-3) M) markedly inhibited [3H]-thymidine incorporation to 27% of control levels when added at the beginning of a 72 h culture period. When added after 24 and 48 h of culture, however, the suppression was much less (62 and 88% of control). Lymphocyte cultures pulsed for 1 h with histamine, washed free of the agent and then cultured with mitogen also showed marked suppression of [3H]-thymidine uptake. The kinetics of the response suggest that histamine acts to inhibit initial processing or recruitment steps in the mitogenic assay. Cimetidine, an H2-receptor blocking agent, prevented the suppressive effect of high levels of histamine while diphenhydramine, an H1 blocker, abolished the enhancement observed with low levels. Pre-incubation of mononuclear cell suspensions, which has been shown to decrease suppressor activity, resulted in a decreased response to added histamine. This change in histamine responsiveness was associated with an alteration in H1:H2 histamine binding as determined with a radiolabelled ligand-binding assay. Histamine suppression of mitogenesis was associated with an increase in cellular cAMP levels while enhancement was accompanied by a small increase in cGMP. These data suggest that lymphocyte function may be regulated, in part, by histamine receptor bearing cells with H1 stimulation having a role in enhancement of mitogenesis and H2 stimulation resulting in normal suppressor activity.

Full text

PDF
107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bresnihan B., Jasin H. E. Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest. 1977 Jan;59(1):106–116. doi: 10.1172/JCI108607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  3. Hatch G. E., Nichols W. K., Hill H. R. A simplified procedure for cyclic nucleotide radioimmunoassay and its application to human blood leukocytes. J Immunol Methods. 1978;19(4):301–308. doi: 10.1016/0022-1759(78)90014-5. [DOI] [PubMed] [Google Scholar]
  4. Hatch G. E., Nichols W. K., Hill H. R. Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators. J Immunol. 1977 Aug;119(2):450–456. [PubMed] [Google Scholar]
  5. Hill H. R., Ochs H. D., Quie P. G., Clark R. A., Pabst H. F., Klebanoff S. J., Wedgwood R. J. Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet. 1974 Sep 14;2(7881):617–619. doi: 10.1016/s0140-6736(74)91942-4. [DOI] [PubMed] [Google Scholar]
  6. Hill H. R., Quie P. G. Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet. 1974 Feb 9;1(7850):183–187. doi: 10.1016/s0140-6736(74)92493-3. [DOI] [PubMed] [Google Scholar]
  7. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McGeady S. J., Buckley R. H. Depression of cell-mediated immunity in atopic eczema. J Allergy Clin Immunol. 1975 Nov;56(5):393–406. doi: 10.1016/0091-6749(75)90133-5. [DOI] [PubMed] [Google Scholar]
  9. Ogden B. E., Krueger G. G., Hill H. R. Lymphocyte suppressor activity in atopic eczema. Clin Exp Immunol. 1979 Feb;35(2):269–275. [PMC free article] [PubMed] [Google Scholar]
  10. Rachelefsky G. S., Opelz G., Mickey M. R., Kiuchi M., Terasaki P. I., Siegel S. C., Stiehm E. R. Defective T cell function in atopic dermatitis. J Allergy Clin Immunol. 1976 Jun;57(6):569–576. doi: 10.1016/0091-6749(76)90008-7. [DOI] [PubMed] [Google Scholar]
  11. Rogge J. L., Hanifin J. M. Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation. Arch Dermatol. 1976 Oct;112(10):1391–1396. [PubMed] [Google Scholar]
  12. Saxon A., Morledge V. D., Bonavida B. Histamine-receptor leucocytes (HRL). Organ and lymphoid subpopulation distribution in man. Clin Exp Immunol. 1977 Jun;28(3):394–399. [PMC free article] [PubMed] [Google Scholar]
  13. Stobo J. D., Paul S., Van Scoy R. E., Hermans P. E. Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest. 1976 Feb;57(2):319–328. doi: 10.1172/JCI108283. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES